Skip to content

Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia

Radiographic Severity Scoring System and Clinical and Laboratory Evolution of COVID-19 Pneumonia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05181696
Acronym
RANCH-COVID
Enrollment
200
Registered
2022-01-06
Start date
2020-01-01
Completion date
2025-05-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pneumonia, Multiorgan Failure, Pneumonia, SARS-CoV-2 Acute Respiratory Disease, Sepsis

Keywords

COVID-19, Acute respiratory distress syndrome (ARDS), Sepsis, Multiorgan Failure, Chest X-ray, Inflammation

Brief summary

The research will be retrospective, and will include all patients who were admitted during 2020 and 2021 in the COVID-19 ICU of University Hospital Center Osijek due to pneumonia caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association of chest x-ray infiltrate evolution with changes in laboratory inflammatory parameters and respiratory function parameters will be examined.

Detailed description

The research will be retrospective, and will include a review of medical history of all patients admitted in the COVID-19 ICU of the University hospital Osijek during 2020 and 2021. Associated comorbidity, hospital admission date, intubation date, mechanical ventilation, extubation, discharge, and patient final outcome will be recorded for each patient. By analyzing X-rays of the lungs by radiology specialists, inflammatory infiltrates in the lungs will be quantified via the Brixia system, during hospital admission, admission to the Respiratory Center, and during treatment at the Respiratory Center. All patients will have their Sequential Organ Failure Assessment (SOFA) and/or Acute Physiology and Chronic Health Evaluation (APACHE II) values calculated upon admission. Inflammatory parameters (c-reactive protein (CRP), procalcitonin (PCT), interleukine-6 (IL-6), ferritin), red blood cell count, leukocytes, blood urea nitrogen (BUN), arterial blood gases and ventilation parameters on admission to the hospital, admission to the ICU, and on several occasions during treatment in the ICU will be analysed. Also, empirical use of antibiotics, the occurrence of bacterial superinfections, sepsis and organic failure will be noted.

Interventions

DIAGNOSTIC_TESTChest X-ray

Retrospective analysis of chest x-rays of patients with COVID-19

Sponsors

Osijek University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Pneumonia caused by SARS-CoV-2 virus * Admission to the ICU COVID-19 unit

Exclusion criteria

\- Patients with lung tumors or history of lung resection

Design outcomes

Primary

MeasureTime frameDescription
Chest x-ray severity score21 daysThe influence of the dynamics of radiographic changes quantified by Brixia score on the outcome of COVID-19 patients will be examined
Inflammatory markers21 daysThe influence of serum levels of inflammatory parameters, and clinical and laboratory indicators of organic failure on chest x-ray severity score will be examined

Countries

Croatia

Contacts

Primary ContactNenad Nešković, PhD
nneskov@gmail.com+395996787250
Backup ContactIvana Haršanji Drenjančević, PhD
ihdrenjan@gmail.com+385915108941

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026